Close Menu

NEW YORK – Cancer detection technology firm StageZero Life Sciences said on Thursday it has raised C$2.7 million ($2.1 million) of its targeted C$3.7 million private placement financing round.

The company, which has offices in Richmond Hill, Ontario, added that it expects the round to close by July 19 and the private placement is fully subscribed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.